Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab

Abstract Background Spontaneous regression of metastatic melanoma and delayed responses more than one year after treatment with ipilimumab are rarely seen. Case presentation Here, we present the case of a patient with in transit metastases from cutaneous melanoma on his right lower extremity who ach...

Full description

Bibliographic Details
Main Authors: Raphael B. Moreira, Lana Hamieh, Evisa Gjini, Ana Lako, Katherine M. Krajewski, Charles H. Yoon, Patrick A. Ott
Format: Article
Language:English
Published: BMJ Publishing Group 2017-07-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
PD-1
Immune checkpoint blockade
Antibody therapy
Melanoma
Immunotherapy
Online Access:http://link.springer.com/article/10.1186/s40425-017-0259-9

Internet

http://link.springer.com/article/10.1186/s40425-017-0259-9

Similar Items